The role of chimeric antigen receptor (CAR) T cell therapy in breast cancer.
Recent advances in CAR-T cell engineering are summarized, the major target antigens investigated to date are discussed, a comprehensive overview of the available clinical evidence, and the key biological and clinical challenges that must be addressed are examined to improve future therapeutic outcomes.